FDA.reportPublic FDA data

sacituzumab govitecan-hziy 180 MG Injection

RxCUI
2360534
RxNorm name
sacituzumab govitecan-hziy 180 MG Injection
Display name
sacituzumab govitecan-hziy 180 MG Injection
Full name
sacituzumab govitecan-hziy 180 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761115Trodelvysacituzumab govitecan-hziy351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TRODELVYSACITUZUMAB GOVITECANGilead Sciences, Inc.57a597d2-03f0-472e-b148-016d7169169d2026-06-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2360534

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
57a597d2-03f0-472e-b148-016d7169169dsacituzumab govitecan-hziy 180 MG Injection [PSN] · sacituzumab govitecan-hziy 180 MG Injection [SCD]218These highlights do not include all the information needed to use TRODELVY safely and effectively. See full prescribing information for TRODELVY TRODELVY ® (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 202020250331